{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:43:37Z","timestamp":1794336217280,"version":"4.9.0"},"reference-count":239,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["DGF601020-1"],"award-info":[{"award-number":["DGF601020-1"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174169"],"award-info":[{"award-number":["82174169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374246"],"award-info":[{"award-number":["82374246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phrs.2025.107958","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:28:52Z","timestamp":1758133732000},"page":"107958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Hyaluronic acid and its role in pancreatic cancer: Mechanisms of tumor progression, drug resistance, and therapeutic targeting"],"prefix":"10.1016","volume":"221","author":[{"given":"Wenxun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suoyi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phrs.2025.107958_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett."},{"issue":"10485","key":"10.1016\/j.phrs.2025.107958_bib3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.phrs.2025.107958_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073995","article-title":"Advances in the management of pancreatic cancer","author":"Del Chiaro","year":"2023","journal-title":"Bmj 383"},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","article-title":"The role of stroma in pancreatic cancer: diagnostic and therapeutic implications","volume":"9","author":"Erkan","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107958_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010124","article-title":"Pancreatic cancer is feeling the heat","volume":"12","author":"Maru","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0925-4439(00)00051-X","article-title":"Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition","volume":"1502","author":"Theocharis","year":"2000","journal-title":"Biochim Biophys. Acta"},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080765","article-title":"Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.phrs.2025.107958_bib14","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","article-title":"Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer","volume":"21","author":"Whatcott","year":"2015","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107958_bib16","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1002\/ijc.32751","article-title":"Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer","volume":"146","author":"Chen","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccr.2014.05.026","article-title":"Pancreatic cancer stroma: friend or foe?","volume":"25","author":"Gore","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020246","article-title":"Initial identification of UDP-Glucose dehydrogenase as a prognostic marker in breast cancer patients, which facilitates epirubicin resistance and regulates hyaluronan synthesis in MDA-MB-231 cells","volume":"11","author":"Vitale","year":"2021","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib20","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.actbio.2013.12.019","article-title":"Hyaluronan: a simple polysaccharide with diverse biological functions","volume":"10","author":"Dicker","year":"2014","journal-title":"Acta Biomater."},{"issue":"15","key":"10.1016\/j.phrs.2025.107958_bib21","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/febs.14847","article-title":"Dissecting the role of hyaluronan synthases in the tumor microenvironment","volume":"286","author":"Passi","year":"2019","journal-title":"Febs J."},{"issue":"12","key":"10.1016\/j.phrs.2025.107958_bib22","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1074\/jbc.M508516200","article-title":"Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian xenopus laevis and its involvement in hyaluronan synthesis","volume":"281","author":"Vigetti","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113808","article-title":"UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis","volume":"43","author":"Fan","year":"2024","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.phrs.2025.107958_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biom14121567","article-title":"Differential regulation of hyaluronan synthesis by three isoforms of hyaluronan synthases in mammalian cells","volume":"14","author":"Wang","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/excr.1999.4645","article-title":"P. Heldin, expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44","volume":"252","author":"Brinck","year":"1999","journal-title":"Exp. Cell Res."},{"issue":"14","key":"10.1016\/j.phrs.2025.107958_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147607","article-title":"Deciphering drug resistance: investigating the emerging role of hyaluronan metabolism and signaling and tumor extracellular matrix in cancer chemotherapy","volume":"25","author":"Vitale","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2025.107958_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s42255-020-00316-0","article-title":"The hexosamine biosynthesis pathway is a targetable liability in KRAS\/LKB1 mutant lung cancer","volume":"2","author":"Kim","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2025.107958_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.010","article-title":"The hexosamine biosynthetic pathway and cancer: current knowledge and future therapeutic strategies","volume":"503","author":"Lam","year":"2021","journal-title":"Cancer Lett."},{"issue":"42","key":"10.1016\/j.phrs.2025.107958_bib29","doi-asserted-by":"crossref","first-page":"28816","DOI":"10.1074\/jbc.M114.597401","article-title":"Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation","volume":"289","author":"Vigetti","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.phrs.2025.107958_bib30","doi-asserted-by":"crossref","first-page":"23647","DOI":"10.1074\/jbc.M110.127050","article-title":"The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination","volume":"285","author":"Karousou","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/glycob\/cww089","article-title":"Hyaluronan synthase control of synthesis rate and hyaluronan product size are independent functions differentially affected by mutations in a conserved tandem B-X7-B motif","volume":"27","author":"Baggenstoss","year":"2017","journal-title":"Glycobiology"},{"issue":"7","key":"10.1016\/j.phrs.2025.107958_bib32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/cr050247k","article-title":"Hyaluronidases: their genomics, structures, and mechanisms of action","volume":"106","author":"Stern","year":"2006","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0945-053X(01)00172-X","article-title":"The six hyaluronidase-like genes in the human and mouse genomes","volume":"20","author":"Csoka","year":"2001","journal-title":"Matrix Biol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib35","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1074\/jbc.M608358200","article-title":"CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by Hyaluronidase-1 and -2","volume":"282","author":"Harada","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0945-053X(01)00170-6","article-title":"Hyal2--less active, but more versatile?","volume":"20","author":"Lepperdinger","year":"2001","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biotechadv.2007.07.001","article-title":"The many ways to cleave hyaluronan","volume":"25","author":"Stern","year":"2007","journal-title":"Biotechnol. Adv."},{"issue":"12","key":"10.1016\/j.phrs.2025.107958_bib38","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1007\/s00432-022-04127-6","article-title":"The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer","volume":"148","author":"Riecks","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib39","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1096\/fj.14-259978","article-title":"A novel role of low molecular weight hyaluronan in breast cancer metastasis","volume":"29","author":"Wu","year":"2015","journal-title":"Faseb J."},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111490","article-title":"Targeting BET proteins decreases Hyaluronidase-1 in pancreatic cancer","volume":"12","author":"Kumar","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.phrs.2025.107958_bib41","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/jgh.14660","article-title":"The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer","volume":"34","author":"Jin","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"14","key":"10.1016\/j.phrs.2025.107958_bib42","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1073\/pnas.1215432110","article-title":"KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization","volume":"110","author":"Yoshida","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.phrs.2025.107958_bib43","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.M116.770149","article-title":"A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase","volume":"292","author":"Yamamoto","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.phrs.2025.107958_bib44","doi-asserted-by":"crossref","first-page":"30910","DOI":"10.1074\/jbc.M115.673566","article-title":"Regulation of hyaluronan (HA) metabolism mediated by HYBID (Hyaluronan-binding Protein Involved in HA Depolymerization, KIAA1199) and HA synthases in growth Factor-stimulated fibroblasts*","volume":"290","author":"Nagaoka","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2018.09.097","article-title":"The role and regulation of TMEM2 (transmembrane protein 2) in HYBID (hyaluronan (HA)-binding protein involved in HA depolymerization\/ KIAA1199\/CEMIP)-mediated HA depolymerization in human skin fibroblasts","volume":"505","author":"Yoshino","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104826","article-title":"Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199\/CEMIP) and HAS2 expression","volume":"299","author":"Sato","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105120","article-title":"TMEM2 is a bona fide hyaluronidase possessing intrinsic catalytic activity","volume":"299","author":"Narita","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2025.107958_bib48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.pan.2020.08.026","article-title":"Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma","volume":"20","author":"Kudo","year":"2020","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97752-z","article-title":"Hypoxia increases KIAA1199\/CEMIP expression and enhances cell migration in pancreatic cancer","volume":"11","author":"Oba","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2025.107958_bib50","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.3390\/ijms21103504","article-title":"Role of the hyaluronan receptor, Stabilin-2\/HARE, in health and disease","volume":"21","author":"Harris","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.phrs.2025.107958_bib51","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1074\/jbc.M112.442889","article-title":"The hyaluronan receptor for endocytosis (HARE) activates NF-\u03baB-mediated gene expression in response to 40\u2013400-kDa, but not smaller or larger, hyaluronans*","volume":"288","author":"Pandey","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107958_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2016.10.001","article-title":"Roles and targeting of the HAS\/hyaluronan\/CD44 molecular system in cancer","volume":"59","author":"Karousou","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.phrs.2025.107958_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fimmu.2015.00236","article-title":"Hyaluronan, inflammation, and breast cancer progression","volume":"6","author":"Schwertfeger","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107958_bib54","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3389\/fimmu.2015.00420","article-title":"Lipid Raft-Mediated regulation of Hyaluronan\u2013CD44 interactions in inflammation and cancer","volume":"6","author":"Murai","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0945-053X(01)00186-X","article-title":"CD44-mediated uptake and degradation of hyaluronan","volume":"21","author":"Knudson","year":"2002","journal-title":"Matrix Biol."},{"issue":"22","key":"10.1016\/j.phrs.2025.107958_bib56","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1158\/1078-0432.CCR-15-3115","article-title":"CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness, and response to therapy","volume":"22","author":"Zhao","year":"2016","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1541-7786.MCR-14-0076","article-title":"CD44 regulates pancreatic cancer invasion through MT1-MMP","volume":"13","author":"Jiang","year":"2015","journal-title":"Molecular cancer research MCR"},{"issue":"20","key":"10.1016\/j.phrs.2025.107958_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012061","article-title":"CD44V3, an alternatively spliced form of CD44, promotes pancreatic cancer progression","volume":"23","author":"Zhu","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/cjp2.122","article-title":"Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancer","volume":"5","author":"Franklin","year":"2019","journal-title":"J. Pathol. Clin. Res"},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib60","first-page":"1831","article-title":"CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma","volume":"55","author":"Rall","year":"1995","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1520-6866(2001)21:1<97::AID-TCM9>3.0.CO;2-O","article-title":"CD44 in normal human pancreas and pancreatic carcinoma cell lines","volume":"21","author":"Ringel","year":"2001","journal-title":"Teratog. Carcinog. Mutagen."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib62","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2015.10.020","article-title":"Inhibition of tumor growth and metastasis in pancreatic cancer models by interference with CD44v6 signaling","volume":"150","author":"Matzke-Ogi","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yexmp.2014.12.001","article-title":"Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis","volume":"98","author":"Kiuchi","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.phrs.2025.107958_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1746-1596-9-79","article-title":"CD44v\/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients","volume":"9","author":"Li","year":"2014","journal-title":"Diagn. Pathol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib65","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","article-title":"Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 axis","volume":"161","author":"Nallasamy","year":"2021","journal-title":"Gastroenterology"},{"issue":"30","key":"10.1016\/j.phrs.2025.107958_bib66","doi-asserted-by":"crossref","first-page":"20941","DOI":"10.18632\/oncotarget.24939","article-title":"Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib67","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7150\/jca.12990","article-title":"Receptor for hyaluronic Acid-Mediated motility is associated with poor survival in pancreatic ductal adenocarcinoma","volume":"6","author":"Cheng","year":"2015","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib68","first-page":"927","article-title":"Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression","volume":"17","author":"Li","year":"2000","journal-title":"Int J. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-019-1018-y","article-title":"Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression","volume":"18","author":"Choi","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2025.107958_bib70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2015.00261","article-title":"The content and size of hyaluronan in biological fluids and tissues","volume":"6","author":"Cowman","year":"2015","journal-title":"Front Immunol."},{"issue":"15","key":"10.1016\/j.phrs.2025.107958_bib71","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1111\/febs.14777","article-title":"Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer","volume":"286","author":"Tavianatou","year":"2019","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib72","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/glycob\/cwx039","article-title":"What is special about 200 kda hyaluronan that activates hyaluronan receptor signaling?","volume":"27","author":"Weigel","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.phrs.2025.107958_bib73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.carbpol.2018.06.015","article-title":"Molecular weight impact on the mechanical forces between hyaluronan and its receptor","volume":"197","author":"Jiang","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib74","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cellsig.2009.01.024","article-title":"Rheostatic signaling by CD44 and hyaluronan","volume":"21","author":"Pur\u00e9","year":"2009","journal-title":"Cell Signal"},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib75","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.18632\/oncotarget.6617","article-title":"Hyaluronan stimulates pancreatic cancer cell motility","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.70001","article-title":"CD44\/Integrin \u03b21 association drives fast motility on hyaluronic acid substrates","volume":"240","author":"Roy","year":"2025","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1083\/jcb.200611058","article-title":"Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells","volume":"176","author":"Kothapalli","year":"2007","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib78","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1158\/1535-7163.MCT-10-0529","article-title":"Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model","volume":"9","author":"Mueller","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib79","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2019.05.167","article-title":"High-molecular-weight hyaluronan produced by activated pancreatic stellate cells promotes pancreatic cancer cell migration via paracrine signaling","volume":"515","author":"Junliang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/cjp2.122","article-title":"Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancer","volume":"5","author":"Franklin","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib81","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib82","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.18632\/oncotarget.6617","article-title":"Hyaluronan stimulates pancreatic cancer cell motility","volume":"7","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2019.05.167","article-title":"High-molecular-weight hyaluronan produced by activated pancreatic stellate cells promotes pancreatic cancer cell migration via paracrine signaling","volume":"515","author":"Junliang","year":"2019","journal-title":"Biochem Biophys. Res Commun."},{"issue":"34","key":"10.1016\/j.phrs.2025.107958_bib84","doi-asserted-by":"crossref","first-page":"32259","DOI":"10.1074\/jbc.M300347200","article-title":"Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells","volume":"278","author":"Sugahara","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib85","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.2014.332","article-title":"Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis","volume":"111","author":"Schmaus","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2025.107958_bib86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.matbio.2023.02.005","article-title":"Targeting LAYN inhibits colorectal cancer metastasis and tumor-associated macrophage infiltration induced by hyaluronan oligosaccharides","volume":"117","author":"Yang","year":"2023","journal-title":"Matrix Biol."},{"issue":"51","key":"10.1016\/j.phrs.2025.107958_bib87","doi-asserted-by":"crossref","first-page":"43094","DOI":"10.1074\/jbc.M112.349209","article-title":"The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering","volume":"287","author":"Yang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090436","article-title":"Preparation, characterization, and inhibition of hyaluronic acid oligosaccharides in Triple-Negative breast cancer","volume":"9","author":"Han","year":"2019","journal-title":"Biomolecules"},{"issue":"41","key":"10.1016\/j.phrs.2025.107958_bib89","doi-asserted-by":"crossref","first-page":"38013","DOI":"10.1074\/jbc.M202404200","article-title":"Hyaluronan oligosaccharides inhibit Anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-Kinase\/Akt cell survival pathway","volume":"277","author":"Ghatak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107958_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128945","article-title":"Sulfated modification of hyaluronan tetrasaccharide enhances its antitumor activity on human lung adenocarcinoma A549 cells in vitro and in vivo","volume":"75","author":"He","year":"2022","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"7458","key":"10.1016\/j.phrs.2025.107958_bib91","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12234","article-title":"High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat","volume":"499","author":"Tian","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib92","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/s41467-020-16050-w","article-title":"Naked mole-rat very-high-molecular-mass hyaluronan exhibits superior cytoprotective properties","volume":"11","author":"Takasugi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107958_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110098","article-title":"Naked mole-rat TMEM2 lacks physiological hyaluronan-degrading activity","volume":"759","author":"Sato","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2025.107958_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2024.11.004","article-title":"Identification of CD44 as a key engager to hyaluronic acid-rich extracellular matrices for cell traction force generation and tumor invasion in 3D","volume":"135","author":"Cheung","year":"2025","journal-title":"Matrix Biol."},{"key":"10.1016\/j.phrs.2025.107958_bib95","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.actbio.2021.06.009","article-title":"Cancer cell migration in collagen-hyaluronan composite extracellular matrices","volume":"130","author":"Unnikandam Veettil","year":"2021","journal-title":"Acta Biomater."},{"issue":"34","key":"10.1016\/j.phrs.2025.107958_bib96","doi-asserted-by":"crossref","first-page":"36762","DOI":"10.18632\/oncotarget.5461","article-title":"CD44-mediated activation of \u03b15\u03b21-integrin, cortactin and paxillin signaling underpins adhesion of basal-like breast cancer cells to endothelium and fibronectin-enriched matrices","volume":"6","author":"McFarlane","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib97","doi-asserted-by":"crossref","DOI":"10.1063\/5.0203028","article-title":"Mutual antagonism between CD44 and integrins in glioblastoma cell traction and migration","volume":"8","author":"Kelly","year":"2024","journal-title":"APL Bioeng."},{"key":"10.1016\/j.phrs.2025.107958_bib98","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.actbio.2023.08.001","article-title":"Molecular weight of hyaluronic acid crosslinked into biomaterial scaffolds affects angiogenic potential","volume":"169","author":"Karam","year":"2023","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib99","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1021\/acsabm.1c00291","article-title":"Hyaluronic acid oligomer immobilization as an angiogenic trigger for the neovascularization of TE constructs","volume":"4","author":"Silva","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2008.12.029","article-title":"Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response","volume":"278","author":"Alaniz","year":"2009","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib101","article-title":"Matrix-Bound hyaluronan molecular weight as a regulator of dendritic cell immune potency","volume":"13","author":"Quartey","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib102","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2007-01-068031","article-title":"Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes","volume":"110","author":"Kuang","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.phrs.2025.107958_bib103","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/acsbiomaterials.5b00181","article-title":"High and low molecular weight hyaluronic acid differentially influence macrophage activation","volume":"1","author":"Rayahin","year":"2015","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.phrs.2025.107958_bib104","doi-asserted-by":"crossref","unstructured":"B.M. Lee, S.J. Park, I. Noh, C.-H. Kim, The effects of the molecular weights of hyaluronic acid on the immune responses, Biomaterials Research 25(1) 27.","DOI":"10.1186\/s40824-021-00228-4"},{"issue":"19","key":"10.1016\/j.phrs.2025.107958_bib105","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1158\/1078-0432.CCR-17-3284","article-title":"Parallel accumulation of tumor hyaluronan, collagen, and other drivers of tumor progression","volume":"24","author":"Li","year":"2018","journal-title":"Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib106","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.phrs.2025.107958_bib107","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1053\/j.gastro.2016.03.040","article-title":"Mounting pressure in the microenvironment: fluids, solids, and cells in pancreatic ductal adenocarcinoma","volume":"150","author":"DuFort","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib108","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ccr.2014.06.003","article-title":"Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure","volume":"26","author":"Chauhan","year":"2014","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib109","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/cas.12913","article-title":"Role of hyaluronan in pancreatic cancer biology and therapy: once again in the spotlight","volume":"107","author":"Sato","year":"2016","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib110","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1074\/jbc.M506740200","article-title":"Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments","volume":"281","author":"Sugahara","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245871","article-title":"CD44 modulates metabolic pathways and altered ROS-mediated akt signal promoting cholangiocarcinoma progression","volume":"16","author":"Thanee","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib112","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/0008-5472.686.65.3","article-title":"Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase\/Akt pathway to enhance the motility of human glioma cells","volume":"65","author":"Kim","year":"2005","journal-title":"Cancer Res"},{"issue":"32","key":"10.1016\/j.phrs.2025.107958_bib113","doi-asserted-by":"crossref","first-page":"29420","DOI":"10.1074\/jbc.M301885200","article-title":"Hyaluronan-mediated CD44 interaction with RhoGEF and rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression","volume":"278","author":"Bourguignon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107958_bib114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12964-020-00592-z","article-title":"Remodelling of the bone marrow microenvironment by stromal hyaluronan modulates the malignancy of breast cancer cells","volume":"18","author":"Chen","year":"2020","journal-title":"Cell Communication Signaling CCS"},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107958_bib116","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actbio.2017.11.025","article-title":"Hyaluronan size alters chondrogenesis of adipose-derived stem cells via the CD44\/ERK\/SOX-9 pathway","volume":"66","author":"Wu","year":"2018","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib117","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41419-022-05103-1","article-title":"Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107958_bib118","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1038\/s41467-021-26259-y","article-title":"Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities","volume":"12","author":"Meng","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.phrs.2025.107958_bib119","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ijc.24573","article-title":"CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells","volume":"125","author":"Hong","year":"2009","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib120","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41563-024-01908-x","article-title":"Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids","volume":"23","author":"LeSavage","year":"2024","journal-title":"Nat. Mater."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087331","article-title":"Identification and clinical significance of pancreatic cancer stem cells and their chemotherapeutic drug resistance","volume":"24","author":"Kuo","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib122","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/onc.2011.222","article-title":"Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan\/CD44-activated head and neck squamous cell carcinoma cells","volume":"31","author":"Bourguignon","year":"2012","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.phrs.2025.107958_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914652","article-title":"Differential effects of pancreatic Cancer-Derived extracellular vesicles driving a suppressive environment","volume":"24","author":"Purushothaman","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib124","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/s41467-023-38064-w","article-title":"HAPLN1 potentiates peritoneal metastasis in pancreatic cancer","volume":"14","author":"Wiedmann","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2025.107958_bib125","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1053\/j.gastro.2022.02.035","article-title":"IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma","volume":"162","author":"Somani","year":"2022","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib126","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1053\/j.gastro.2016.06.005","article-title":"ETS-Transcription factor ETV1 regulates stromal expansion and metastasis in pancreatic cancer","volume":"151","author":"Heeg","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib127","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-019-1023-1","article-title":"Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer","volume":"18","author":"Weng","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib128","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91796-x","article-title":"Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer","volume":"11","author":"Tahkola","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2025.107958_bib129","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1096\/fj.04-3000fje","article-title":"Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers","volume":"19","author":"Mauri","year":"2005","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1158\/1535-7163.MCT-14-0580","article-title":"Tumor-Associated hyaluronan limits efficacy of monoclonal antibody therapy","volume":"14","author":"Singha","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2025.107958_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00512","article-title":"Versican\u2014A critical extracellular matrix regulator of immunity and inflammation","volume":"11","author":"Wight","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib132","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.matbio.2011.10.004","article-title":"Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration","volume":"31","author":"Evanko","year":"2012","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib133","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1172154","article-title":"A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib134","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1039\/C9BM00155G","article-title":"Hyaluronic acid-based extracellular matrix triggers spontaneous M2-like polarity of monocyte\/macrophage","volume":"7","author":"Kim","year":"2019","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082061","article-title":"Hyaluronan and its receptors: key mediators of immune cell entry and trafficking in the lymphatic system","volume":"10","author":"Johnson","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib136","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/cancers12051325","article-title":"Tumor cell associated Hyaluronan-CD44 signaling promotes Pro-Tumor inflammation in breast cancer","volume":"12","author":"Witschen","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib137","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/0008-5472.CAN-20-1144","article-title":"Hyal2 expression in Tumor-Associated myeloid cells mediates Cancer-Related inflammation in bladder cancer","volume":"81","author":"Dominguez-Gutierrez","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2025.107958_bib138","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62645","article-title":"Hyaluronic acid fuels pancreatic cancer cell growth","volume":"10","author":"Kim","year":"2021","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib139","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/1535-7163.MCT-10-0470","article-title":"Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models","volume":"9","author":"Thompson","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.phrs.2025.107958_bib141","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1158\/1078-0432.CCR-15-2010","article-title":"Phase ib study of PEGylated recombinant human hyaluronidase and gemcitabine in patients with advanced pancreatic cancer","volume":"22","author":"Hingorani","year":"2016","journal-title":"Clin. Cancer Res"},{"issue":"13","key":"10.1016\/j.phrs.2025.107958_bib142","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1200\/JCO.18.01295","article-title":"Phase IB\/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313","volume":"37","author":"Ramanathan","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib143","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.2017.74.9564","article-title":"HALO 202: randomized phase II study of PEGPH20 plus Nab-Paclitaxel\/Gemcitabine versus Nab-Paclitaxel\/Gemcitabine in patients with untreated, metastatic pancreatic ductal adenocarcinoma","volume":"36","author":"Hingorani","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"27","key":"10.1016\/j.phrs.2025.107958_bib144","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase alfa with Nab-Paclitaxel plus gemcitabine for patients with Hyaluronan-High metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.phrs.2025.107958_bib145","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1158\/1078-0432.CCR-18-4192","article-title":"Dissecting the stromal signaling and regulation of myeloid cells and memory effector t cells in pancreatic cancer","volume":"25","author":"Blair","year":"2019","journal-title":"Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib146","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyad022","article-title":"Atezolizumab plus PEGPH20 versus chemotherapy in advanced pancreatic ductal adenocarcinoma and gastric cancer: MORPHEUS phase Ib\/II umbrella randomized study platform","volume":"28","author":"Ko","year":"2023","journal-title":"Oncologist"},{"issue":"4_","key":"10.1016\/j.phrs.2025.107958_bib147","article-title":"Phase II study of PEGPH20 plus pembrolizumab for patients (pts) with hyaluronan (HA)-high refractory metastatic pancreatic adenocarcinoma (mPC): PCRT16-001","volume":"40","author":"Zhen","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib148","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/j.gastro.2022.06.027","article-title":"Dual stromal targeting sensitizes pancreatic adenocarcinoma for Anti-Programmed cell death protein 1 therapy","volume":"163","author":"Blair","year":"2022","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.phrs.2025.107958_bib149","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1158\/0008-5472.CAN-18-3060","article-title":"Remodeling the tumor microenvironment sensitizes breast tumors to Anti-Programmed Death-Ligand 1 immunotherapy","volume":"79","author":"Clift","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2025.107958_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100793","article-title":"PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study","volume":"30","author":"Seki","year":"2022","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111458","article-title":"Tumor-Colonizing E. Coli expressing both collagenase and hyaluronidase enhances therapeutic efficacy of gemcitabine in pancreatic cancer models","volume":"14","author":"Avsharian","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib152","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/1535-7163.MCT-19-0556","article-title":"Hyaluronidase-Expressing salmonella effectively targets Tumor-Associated hyaluronic acid in pancreatic ductal adenocarcinoma","volume":"19","author":"Ebelt","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2025.107958_bib153","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2023.02.001","article-title":"ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models","volume":"355","author":"Kim","year":"2023","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib154","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008431","article-title":"An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003254","article-title":"VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects","volume":"9","author":"Bazan-Peregrino","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib156","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003255","article-title":"Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors","volume":"10","author":"Garcia-Carbonero","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib157","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.yexcr.2009.03.002","article-title":"4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3","volume":"315","author":"Kultti","year":"2009","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib158","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbrc.2006.05.037","article-title":"Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL)","volume":"345","author":"Morohashi","year":"2006","journal-title":"Biochem Biophys. Res Commun."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib159","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbrc.2006.05.037","article-title":"Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL)","volume":"345","author":"Morohashi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.phrs.2025.107958_bib160","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/ijc.22349","article-title":"Inhibitory effect of 4-methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer in vitro and in nude mice","volume":"120","author":"Hajime","year":"2007","journal-title":"Int J. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib161","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00280-005-0016-5","article-title":"4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells","volume":"57","author":"Nakazawa","year":"2006","journal-title":"Cancer Chemother. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2025.107958_bib162","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.21873\/anticanres.12919","article-title":"4-Methylumbelliferone decreases the Hyaluronan-rich extracellular matrix and increases the effectiveness of 5-Fluorouracil","volume":"38","author":"Yoshida","year":"2018","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib163","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1634\/theoncologist.2014-0086","article-title":"Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma","volume":"19","author":"Wolpin","year":"2014","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib164","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-15-1155","article-title":"Impaired synthesis of stromal components in response to minnelide improves vascular function, drug delivery, and survival in pancreatic cancer","volume":"22","author":"Banerjee","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2025.107958_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215591","article-title":"Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer","volume":"537","author":"Modi","year":"2022","journal-title":"Cancer Lett."},{"issue":"20","key":"10.1016\/j.phrs.2025.107958_bib166","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2217\/fon-2021-1609","article-title":"A phase II trial of the super-enhancer inhibitor Minnelide\u2122 in advanced refractory adenosquamous carcinoma of the pancreas","volume":"18","author":"Skorupan","year":"2022","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib167","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12935-020-01711-z","article-title":"Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44\/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/srep39044","article-title":"High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib169","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI127515","article-title":"Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy","volume":"130","author":"Sharma","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.phrs.2025.107958_bib170","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1021\/acsnano.4c14969","article-title":"siRNA-Encapsulated biomimetic liposomes effectively inhibit tumor cells' hexosamine biosynthesis pathway for attenuating hyaluronan barriers to pancreatic cancer chemotherapy","volume":"19","author":"Wu","year":"2025","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib171","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88032","article-title":"BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo","volume":"2","author":"Kumar","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib172","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1053\/j.gastro.2013.12.035","article-title":"Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"issue":"48","key":"10.1016\/j.phrs.2025.107958_bib173","doi-asserted-by":"crossref","first-page":"80046","DOI":"10.18632\/oncotarget.11098","article-title":"First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors","volume":"7","author":"Menke-van der Houven van Oordt","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2025.107958_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108212","article-title":"New N-Alkylketonetetrahydroisoquinoline derivatives exhibits antitumor effect by HA-CD44 interaction inhibition in MDA-MB-231 breast cancer","volume":"156","author":"Chayah","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"17","key":"10.1016\/j.phrs.2025.107958_bib175","doi-asserted-by":"crossref","first-page":"23772","DOI":"10.18632\/oncotarget.8180","article-title":"Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells","volume":"7","author":"Aguirre-Alvarado","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2025.107958_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101968","article-title":"Oxidative damage to hyaluronan\u2013CD44 interactions as an underlying mechanism of action of oxidative stress-inducing cancer therapy","volume":"43","author":"Yusupov","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2025.107958_bib177","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcis.2023.12.166","article-title":"Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs","volume":"659","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.phrs.2025.107958_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123637","article-title":"Targeted delivery of genistein for pancreatic cancer treatment using hyaluronic-coated cubosomes bioactivated with frankincense oil","volume":"649","author":"Sallam","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib179","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.apsb.2018.11.006","article-title":"Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy","volume":"9","author":"Zhong","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2025.107958_bib180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jconrel.2024.07.058","article-title":"Intelligent micelles for on-demand drug delivery targeting extracellular matrix of pancreatic cancer","volume":"373","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2025.107958_bib181","doi-asserted-by":"crossref","unstructured":"S. Xiao, S. Huang, X. Yang, Y. Lei, M. Chang, J. Hu, Y. Meng, G. Zheng, X. Chen, The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery, Drug Delivery 30(1) 2162156.","DOI":"10.1080\/10717544.2022.2162156"},{"issue":"41","key":"10.1016\/j.phrs.2025.107958_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309464","article-title":"Highly efficient synergistic chemotherapy and magnetic resonance imaging for targeted ovarian cancer therapy using hyaluronic Acid-Coated coordination polymer nanoparticles","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2025.107958_bib183","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcis.2024.07.241","article-title":"Tumor-targeted delivery of hyaluronic acid\/polydopamine-coated Fe2+-doped nano-scaled metal\u2013organic frameworks with doxorubicin payload for glutathione depletion-amplified chemodynamic-chemo cancer therapy","volume":"677","author":"Liang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.phrs.2025.107958_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122196","article-title":"Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer","volume":"338","author":"Sharma","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107958_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135271","article-title":"Hyaluronic acid-covered ferric ion-rich nanobullets with high zoledronic acid payload for breast tumor-targeted chemo\/chemodynamic therapy","volume":"279","author":"Yeh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2025.107958_bib186","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcis.2023.12.166","article-title":"Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs","volume":"659","author":"Bartkowski","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.phrs.2025.107958_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213217","article-title":"An oligomeric hyaluronic acid-GX1 molecular target drug with polyvalent targeting to CD44 and VEGF receptors","volume":"144","author":"Jing","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.phrs.2025.107958_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120255","article-title":"Combinatorial synthesis of a hyaluronan based polysaccharide library for enhanced CD44 binding","volume":"300","author":"Liu","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107958_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122129","article-title":"Enzymatically stable unsaturated hyaluronan-derived oligosaccharides with selective cytostatic properties","volume":"336","author":"Klejch","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107958_bib190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.matbio.2022.04.001","article-title":"Sulfated hyaluronic acid inhibits the hyaluronidase CEMIP and regulates the HA metabolism, proliferation and differentiation of fibroblasts","volume":"109","author":"Schmaus","year":"2022","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib191","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/acc8ac","article-title":"A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulator","volume":"18","author":"Zhang","year":"2023","journal-title":"Biomed. Mater."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib192","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1002\/jcp.27297","article-title":"Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: a preliminary in vitro study","volume":"234","author":"Serri","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2025.107958_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134135","article-title":"Targeted codelivery of doxorubicin and oleanolic acid by reduction responsive hyaluronic acid-based prodrug nano-micelles for enhanced antitumor activity and reduced toxicity","volume":"277","author":"Kong","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"17","key":"10.1016\/j.phrs.2025.107958_bib194","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202412707","article-title":"Dual Cascade-Responsive multifunctional nanoparticles to overcome Bacterium-Induced drug inactivation and enhanced photodynamic and Chemo-Immunotherapy of pancreatic cancer","volume":"21","author":"Li","year":"2025","journal-title":"Small"},{"issue":"17","key":"10.1016\/j.phrs.2025.107958_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202412707","article-title":"Dual Cascade-Responsive multifunctional nanoparticles to overcome Bacterium-Induced drug inactivation and enhanced photodynamic and Chemo-Immunotherapy of pancreatic cancer","volume":"21","author":"Li","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.phrs.2025.107958_bib196","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2017.08.016","article-title":"A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer","volume":"267","author":"Vogus","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2025.107958_bib197","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jconrel.2023.07.014","article-title":"A \"bulldozer\" driven by anoxic bacteria for pancreatic cancer chemo-immunotherapy","volume":"360","author":"Zhang","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2025.107958_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113642","article-title":"Quercetin liposomes conjugated with hyaluronidase: an efficient drug delivery system to block pancreatic cancer","volume":"382","author":"Sun","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2025.107958_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113642","article-title":"Quercetin liposomes conjugated with hyaluronidase: an efficient drug delivery system to block pancreatic cancer","volume":"382","author":"Sun","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2025.107958_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121516","article-title":"Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy","volume":"284","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2025.107958_bib201","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40580-023-00406-1","article-title":"Tailoring tumor-recognizable hyaluronic acid\u2013lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells","volume":"10","author":"Lee","year":"2023","journal-title":"Nano Converg."},{"issue":"24","key":"10.1016\/j.phrs.2025.107958_bib202","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202306738","article-title":"Surface engineering of natural killer cells with CD44-targeting ligands for augmented cancer immunotherapy","volume":"20","author":"Kim","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib203","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-023-40270-5","article-title":"Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107958_bib204","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-023-40270-5","article-title":"Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2011.06.031","article-title":"Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response","volume":"156","author":"Mizrahy","year":"2011","journal-title":"J. Control Release"},{"issue":"25","key":"10.1016\/j.phrs.2025.107958_bib206","doi-asserted-by":"crossref","first-page":"13048","DOI":"10.1021\/acs.analchem.5c00272","article-title":"Studying the effect of receptors clustering on hyaluronic acid binding with CD44 and the cell entry of hyaluronic acid targeting nanodrugs at single Molecule\/Particle level","volume":"97","author":"Li","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.phrs.2025.107958_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116798","article-title":"Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells","volume":"248","author":"Cano","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107958_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.578008","article-title":"Effects of the molecular weight of hyaluronic acid in a carbon nanotube drug delivery conjugate","volume":"8","author":"Arpicco","year":"2020","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib209","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/ph15010103","article-title":"CD44-Targeted carriers: the role of molecular weight of hyaluronic acid in the uptake of hyaluronic Acid-Based nanoparticles","volume":"15","author":"Chiesa","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"27","key":"10.1016\/j.phrs.2025.107958_bib210","doi-asserted-by":"crossref","first-page":"16256","DOI":"10.1039\/D5NR00808E","article-title":"Upholding hyaluronic acid's multi-functionality for nucleic acid drug delivery to target EMT in breast cancer","volume":"17","author":"Isert","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.phrs.2025.107958_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117927","article-title":"How the molecular weight affects the in vivo fate of exogenous hyaluronan delivered intravenously: a stable-isotope labelling strategy","volume":"263","author":"\u0160imek","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"7","key":"10.1016\/j.phrs.2025.107958_bib212","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/cells9071681","article-title":"Addition of high molecular weight hyaluronic acid to Fibroblast-Like stromal cells modulates endogenous hyaluronic acid metabolism and enhances proteolytic processing and secretion of versican","volume":"9","author":"Xue","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib213","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/biology13050319","article-title":"High-Molecular-Weight hyaluronic acid can be used as a food additive to improve the symptoms of persistent inflammation, immunosuppression and catabolism syndrome (PICS)","volume":"13","author":"Jiang","year":"2024","journal-title":"Biology"},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib214","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1349-7006.2009.01084.x","article-title":"Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo","volume":"100","author":"Teranishi","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2025.107958_bib215","doi-asserted-by":"crossref","DOI":"10.1200\/PO.17.00121","article-title":"Stromal content is correlated with tissue site, contrast retention, and survival in pancreatic adenocarcinoma","author":"Torphy","year":"2018","journal-title":"JCO Precis Oncol. 2018"},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib216","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.phrs.2025.107958_bib217","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1158\/1078-0432.CCR-08-0291","article-title":"Sonic hedgehog promotes desmoplasia in pancreatic cancer","volume":"14","author":"Bailey","year":"2008","journal-title":"Clin. Cancer Res"},{"issue":"5933","key":"10.1016\/j.phrs.2025.107958_bib218","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"issue":"36","key":"10.1016\/j.phrs.2025.107958_bib219","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.phrs.2025.107958_bib220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1411679111","article-title":"Stromal response to hedgehog signaling restrains pancreatic cancer progression","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib221","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2025.107958_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100481","article-title":"The cell surface hyaluronidase TMEM2 regulates cell adhesion and migration via degradation of hyaluronan at focal adhesion sites","volume":"296","author":"Irie","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib223","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pan.2016.12.007","article-title":"KIAA1199\/CEMIP\/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma","volume":"17","author":"Koga","year":"2017","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib224","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pan.2021.09.015","article-title":"Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: primary tumors compared to sites of metastasis","volume":"22","author":"Placencio-Hickok","year":"2022","journal-title":"Pancreatology"},{"issue":"16","key":"10.1016\/j.phrs.2025.107958_bib225","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1111\/febs.14859","article-title":"Colorectal cancer-associated \u223c 6 kda hyaluronan serves as a novel biomarker for cancer progression and metastasis","volume":"286","author":"Zhang","year":"2019","journal-title":"Febs J."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib226","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34445-0","article-title":"Molecular weight of surface immobilized hyaluronic acid influences CD44-mediated binding of gastric cancer cells","volume":"8","author":"Amorim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107958_bib227","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.actbio.2020.10.024","article-title":"Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation","volume":"119","author":"Carvalho","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2025.107958_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128945","article-title":"Sulfated modification of hyaluronan tetrasaccharide enhances its antitumor activity on human lung adenocarcinoma A549 cells in vitro and in vivo","volume":"75","author":"He","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib229","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1167\/iovs.13-13759","article-title":"Pirfenidone attenuates the IL-1\u03b2-induced hyaluronic acid increase in orbital fibroblasts from patients with thyroid-associated ophthalmopathy","volume":"55","author":"Chung","year":"2014","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2025.107958_bib230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bjd.16423","article-title":"Hyaluronan metabolism enhanced during epidermal differentiation is suppressed by vitamin c","volume":"179","author":"H\u00e4m\u00e4l\u00e4inen","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2025.107958_bib231","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.actbio.2022.05.013","article-title":"RHAMM expression tunes the response of breast cancer cell lines to hyaluronan","volume":"146","author":"Carvalho","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2025.107958_bib232","doi-asserted-by":"crossref","unstructured":"S. Bhattacharjee, F. Hamberger, A. Ravichandra, M. Miller, A. Nair, S. Affo, A. Filliol, L. Chin, T.M. Savage, D. Yin, N.M. Wirsik, A. Mehal, N. Arpaia, E. Seki, M. Mack, D. Zhu, P.A. Sims, R. Kalluri, B.Z. Stanger, K.P. Olive, T. Schmidt, R.G. Wells, I. Mederacke, R.F. Schwabe, Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts, The Journal of Clinical Investigation 131(11) e146987.","DOI":"10.1172\/JCI146987"},{"issue":"6","key":"10.1016\/j.phrs.2025.107958_bib233","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.phrs.2025.107958_bib234","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080765","article-title":"Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma","volume":"8","author":"Cheng","year":"2013","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.phrs.2025.107958_bib235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejso.2018.09.020","article-title":"High cytoplasm HABP1 expression as a predictor of poor survival and late tumor stage in pancreatic ductal adenocarcinoma patients","volume":"45","author":"Xie","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107958_bib236","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3892\/ol.2022.13343","article-title":"Prognostic and functional role of hyaluronan-binding protein 1 in pancreatic ductal adenocarcinoma","volume":"24","author":"Adachi","year":"2022","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.phrs.2025.107958_bib237","first-page":"191","article-title":"Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study","volume":"429","author":"Castell\u00e0","year":"1996","journal-title":"Virchows Arch."},{"issue":"5","key":"10.1016\/j.phrs.2025.107958_bib238","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/cts.13041","article-title":"Safety and pharmacokinetics of docetaxel in combination with pegvorhyaluronidase alfa in patients with non-small cell lung cancer","volume":"14","author":"Heineman","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.phrs.2025.107958_bib239","doi-asserted-by":"crossref","first-page":"ix171","DOI":"10.1093\/annonc\/mdz437.032","article-title":"506P - efficacy and safety of pegvorhyaluronidase alfa (PEGPH20; PVHA) and pembrolizumab (pembro) combination therapy in patients (Pts) with stage III\/IV non-small cell lung cancer (NSCLC)","volume":"30","author":"Ward","year":"2019","journal-title":"Ann. Oncol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:37:55Z","timestamp":1778582275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":239,"alternative-id":["S1043661825003834"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107958","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid and its role in pancreatic cancer: Mechanisms of tumor progression, drug resistance, and therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107958"}}